Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Advisorshares Pure US Cannabis ETF (NY: MSOS )

4.570 -0.190 (-3.99%)
Official Closing Price Updated: 8:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Advisorshares Pure US Cannabis ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
DEA's Call For Public Input On Cannabis Garnered 42,000 Comments: Majority Want Total Legalization Or Rescheduling
Via Benzinga
Topics Cannabis
Exposures Cannabis
Atlas Shrugged… And the Market Rallied
You’d assume the degree of uncertainty surrounding one of the most important offices in the world would ignite turmoil in the market but it hasn’t. 
Via Talk Markets
'Opaque Political Processes,' DEA Rescheduling Deadline, And Now A New Presidential Candidate, It's No Wonder Cannabis Stocks Are Over The Place
Cannabis stocks faced a mixed week with Ascend Wellness rallying on debt refinancing news, while Jushi Holdings saw a decline. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
The Trump Card: How Would His Second Term Treat Cannabis?
Via Benzinga
Topics Government
Exposures Political
Make America Green Again: U.S. Cannabis Has Bipartisan Support
By Todd Harrison via Cannabis Confidential (May 22) 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Did Pot Just Pivot? Cannabis Preps For Possible Presidential Run
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
President Joe Biden's announcement that he will not seek re-election has impacted the cannabis stock market. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?
With Joe Biden out of the presidential race and Kamala Harris likely in, we analyze what's next for cannabis legalization. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years
Many cannabis companies simply can't continue on their current paths for much longer. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Zero Fees, High Hopes: WEED ETF's Strategy To Capitalize On Impending Cannabis Rescheduling
Roundhill's WEED ETF drops fees to 0%, leveraging anticipated rescheduling. Discover the impact and investment opportunities in cannabis ETFs. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts about the president's electability circulate, questions 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
U.S. Dollar Soars: How Does This Threaten Your Cannabis Investments? Confidential Insights
In a recent issue of "Cannabis Confidential," Todd Harrison provides a succinct analysis of the current market dynamics within the cannabis industry, particularly highlighting the performance... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Cannabis Stocks to Buy Now: June 2024
Cannabis may be controversial. But it’s also proving to be one of the most profitable, with some of the top cannabis stocks to buy now. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
What Is The Trump Factor? Justice Dept's Impact On Cannabis Rescheduling, Stocks And Investments
Equity research firm Zuanic & Associates convened a panel in mid-June featuring industry experts to dissect the ongoing cannabis rescheduling efforts in the US. They provided a comprehensive outlook on... 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Why The Time To Invest In U.S. Cannabis Stocks Is Right Now
The U.S. cannabis market presents a significantly skewed risk-reward opportunity, particularly within the realm of multi-state operators (MSOs). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 3 Most Undervalued Cannabis Stocks to Buy in June 2024
Undervalued cannabis stocks may be some of the most controversial trades on the market. But they’ve also proven themselves profitable. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
Acquisitions have played a big role in Tilray Brands' strategy, and the company is still not done wheeling and dealing. 
Via The Motley Fool
The 2024 Millionaire’s Club: 7 Cannabis Stocks to Buy Now
One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. Here are seven to consider. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
$514M Tax Breaks Await This Marijuana Company With Rescheduling, Market Cap Set To Soar
Jushi Holdings Inc. (OTC: JUSHF) is poised for substantial growth with potential adult-use cannabis legalization in Ohio and Pennsylvania as well as continuous expansion in Virginia’s medical market. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Cannabis Stocks That Could Be Millionaire-Makers: May Edition
Cannabis stocks to buy are surging after the DOJ proposed reclassifying marijuana, signaling a promising future. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Surged On Marijuana Rescheduling News: WTR's Industry Report Analyzes What's Behind The Optimism
DOJ proposes reclassifying cannabis to Schedule III. WTR's report highlights market gains and potential industry impacts. Read insights now! 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Explore how DOJ's cannabis rescheduling boosts stocks and insights from Emily Paxhia on the industry's future. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling
Cannabis stocks are among the big movers investors are watching closely as a key piece of legislation is pushed forward for this sector. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a major leap forward and opportunity to correct long-standing wrongs and improve... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Stocks Rally After Biden Makes Marijuana Reclassification Announcement
Shares of marijuana growers and related companies are trading higher Thursday after President Biden announced that the Department of Justice has moved to reclassify marijuana from a Schedule I... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
Some of the most undervalued cannabis stocks could race to higher highs on several key catalysts this year. Here are seven. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Bullish on Marijuana Reform? This Cannabis-Focused ETF Could Be the Best Way to Invest in Pot Stocks.
This fund can reduce your risk while still giving you the potential to earn some great returns from the cannabis industry's top stocks. 
Via The Motley Fool
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.